An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis.
1,20 €Pomel S, Cojean S, Pons V, Cintrat JC, Nguyen L, Vacus J, Pruvost A, Barbier J, Gillet D, Loiseau PM
Journal of Antimicrobial Chemotherapy
MTH-Paris